Biotech

All Articles

F 2G rears $100M for 2nd attempt to acquire brand new antifungal to market

.After F2G's first effort to get a brand-new course of antifungal to market was actually hindered du...

Moderna targets $1.1 B in R&ampD costs slices, drops 5 courses surrounded by profitability stress

.Moderna has vowed to cut R&ampD investing by $1.1 billion through 2027. The decision to retract the...

Sanofi's $80M bet on Key dystrophy medicine finishes in stage 3 lose big

.Simply four months after Sanofi wager $80 million in ahead of time money on Fulcrum Therapies' losm...

Oncternal stock drains 60% surrounded by discharges, test terminations

.Cancer cells provider Oncternal Therapies is folding all its own medical tests as well as giving up...

Roche is carrying out hopes that its injectable obesity prospect can eventually show 25% weight loss in late-stage test

.Roche is actually keeping out chances that its injectable excessive weight prospect can inevitably ...

Novo Nordisk hails 'amazing' weight loss result for dual-acting dental medicine in very early trial

.Novo Nordisk has actually lifted the top on a stage 1 test of its own dental amylin and also GLP-1 ...

AbbVie files suit BeiGene over blood cancer medicine secret method

.Only a few brief weeks after gaining an FDA Fast lane tag for its investigational BTK degrader in p...

Lilly supplies one-two hit along with second tranche of beneficial data on every week insulin prospect

.Quickly after a favorable data decrease for Eli Lilly's efsitora alfa, the Indianapolis-based firm ...

BridgeBio cuts gene treatment budget as clinical data let down

.BridgeBio Pharma is actually lowering its own genetics therapy budget and drawing back coming from ...

GSK relinquishes HSV vaccine wishes after stage 2 neglect, delivering ethnicity to Moderna, BioNTech

.GSK's try to create the 1st vaccine for genital herpes simplex infection (HSV) has ended in failing...